On Friday, June 12, 2026, the Celiac Disease Foundation and the Society for the Study of Celiac Disease hosted the 2026 National Celiac Disease Policy Symposium, “From Diagnosis to Coverage: Aligning Policy for Celiac Disease Therapeutics.” This virtual symposium was the first step in getting doctors, diagnostic experts, regulators, and health insurance companies on the same page so that once new celiac disease treatments are approved, there’s a clear and fair process for deciding who qualifies and how those treatments get covered.
Thank you to our sponsors Takeda Pharmaceuticals, the Michael Weiss Family, Forte Biosciences, Chugai Pharmaceuticals, and First Tracks Biotherapeutics for enabling this important event to happen.
Watch the recordings and learn more at the link in our bio.